Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (19 ops.)
Latest filing published 20 Oct 2026 for ELI LILLY & Co, €14k.
Filing timeline
BuySaleJuan R. Luciano
Insider track record
Disclosed buys
3
Disclosed sells
19
Signal history
Closed purchases
Market purchases
3
Positive at T+90
67%
Median T+90
+8.6%
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +41.1%Entry US$59.72 · Close at T+365 US$84.26
- +16.8%Entry US$37.28 · Close at T+365 US$43.55
- -13.9%Entry US$44.60 · Close at T+365 US$38.41
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Juan R. Luciano: trading record in brief
Juan R. Luciano publishes a median of 1 day after the trade, and the record reaches 202 filings between February 5, 2016 and October 20, 2026, split evenly between Archer-Daniels-Midland Co (101, "President & CEO") and Eli Lilly & Co (101, "Director"). The annual peak is 2022 with 33 filings, ahead of 2024 with 30.
There are 19 open-market sales, for EUR 97.8 million and a median of EUR 3,262,903. All the largest are at Archer-Daniels-Midland Co: EUR 17,583,105 on October 26, 2022, EUR 15,199,926 on September 9, 2022 and EUR 10,176,206, also on October 26, 2022. Three purchases, also at Archer-Daniels-Midland Co, come to EUR 1.9 million: EUR 894,658 on April 29, 2019, EUR 840,579 on July 29, 2021 and EUR 178,459 on August 6, 2019, which is 14% of open-market trades.
The record also holds 142 grants, 14 option exercises and 24 filings of another type. Over the last 12 months, 20 filings were published, with no purchase or sale.
Companies and markets linked to Juan R. Luciano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations202 total
12.833 shares@ US$1,240.340.0000% mcap0.7% of flowCommon StockSEC:0000059478-26-000099:0
13.664 shares@ US$1,164.891.6% of flowCommon StockSEC:0000059478-26-000091:0
13.453 shares@ US$1,183.160.0000% mcap1.6% of flowCommon StockSEC:0000059478-26-000087:0
13.878 shares@ US$1,146.900.0000% mcap1.6% of flowCommon StockSEC:0000059478-26-000068:0
14.094 sharesCommon StockSEC:0000059478-26-000059:0
17.303 shares@ US$919.900.0000% mcap1.5% of flowCommon StockSEC:0000059478-26-000038:0
16,882 shares@ US$68.641.1% of flowCommon StockSEC:0001225208-26-004014:0
16.092 shares@ US$989.121.6% of flowCommon StockSEC:0000059478-26-000025:0
15.363 shares@ US$1,036.051.5% of flowCommon StockSEC:0000059478-26-000017:0
23,330 shares@ US$69.500.5% of flowCommon StockSEC:0001225208-26-001977:1
106,475 shares0Common StockSEC:0001225208-26-001977:0
12,842 shares@ US$66.330.8% of flowCommon StockSEC:0001225208-26-001638:1
36,249 shares@ US$66.332.1% of flowCommon StockSEC:0001225208-26-001638:2
81,825 shares0Common StockSEC:0001225208-26-001638:0
414,728 shares@ US$67.349.5% of flowCommon StockSEC:0001225208-26-001466:1
581,099 shares@ US$33.1817.2% of flowCommon StockSEC:0001225208-26-001466:0
15.286 shares@ US$1,041.291.5% of flowCommon StockSEC:0000059478-26-000005:0
13.965 shares@ US$1,062.191.4% of flowCommon StockSEC:0000059478-25-000275:0
215.33 shares@ US$1,021.706.9% of flowCommon StockSEC:0000059478-25-000264:1
14.518 shares@ US$1,021.701.4% of flowCommon StockSEC:0000059478-25-000264:0
18.336 shares@ US$808.961.4% of flowCommon StockSEC:0000059478-25-000247:0
19.826 shares@ US$748.191.4% of flowCommon StockSEC:0000059478-25-000242:0
21.25 shares@ US$698.051.4% of flowCommon StockSEC:0000059478-25-000230:0
19.462 shares@ US$762.181.4% of flowCommon StockSEC:0000059478-25-000196:0
18.368 shares@ US$807.581.5% of flowCommon StockSEC:0000059478-25-000174:0
25 of 202 declarations
